U.S. Eyes $90 Million Contract for Bioterror Treatments

Firefighters treat a mock bioterrorism victim during a 2013 drill in Oregon. The U.S. Health and Human Services Department could award up to $90 million over five years to develop a new treatment against glanders and melioidosis.
National Journal
Diane Barnes
Feb. 5, 2014, 10:06 a.m.

A U.S. agency said it could spend some $90 mil­lion over the next five years on a new treat­ment against two po­ten­tially feas­ible bi­o­ter­ror­ism agents.

The Health and Hu­man Ser­vices De­part­ment on Wed­nes­day said a Medi­cines Com­pany-owned firm will ini­tially re­ceive $19.8 mil­lion for work on Car­bavance, its de­vel­op­ment­al coun­ter­meas­ure for glanders and melioidos­is dis­eases.

Both bac­teria are con­sidered to be pos­sibly suited to­ward use as bio­lo­gic­al weapons. Up to nine of 10 un­treated in­fec­tions in­volving either patho­gen can res­ult in death, ac­cord­ing to an agency press re­lease. Health and Hu­man Ser­vices said the agents can de­vel­op res­ist­ance to an­ti­bi­ot­ics; with drugs now avail­able, the odds of dy­ing still stand at roughly two in five.

The con­tract award marked a new in­vest­ment in “broad-spec­trum an­ti­mi­cro­bi­als” by the fed­er­al agency’s Bio­med­ic­al Ad­vanced Re­search and De­vel­op­ment Au­thor­ity. Such treat­ments are de­signed to be of use in re­spond­ing to a po­ten­tial bio­lo­gic­al strike, as well as for hand­ling oth­er health threats.

“An­ti­bi­ot­ic res­ist­ance ad­versely im­pacts our na­tion’s abil­ity to re­spond ef­fect­ively to a bi­o­ter­ror­ism at­tack and to every­day pub­lic health threats,” BARDA Dir­ect­or Robin Robin­son said in a state­ment. “By part­ner­ing with in­dustry to de­vel­op nov­el an­ti­mi­cro­bi­al drugs against bio­threats that also treat drug-res­ist­ant bac­teria, we can ad­dress health se­cur­ity and pub­lic health needs ef­fi­ciently.”

Glanders is a res­pir­at­ory ill­ness spread by bac­teria that can either be breathed in or picked up by phys­ic­al con­tact with con­tam­in­ated an­im­als. Melioidos­is, also known as Whit­more’s dis­ease, is trans­mit­ted via in­hal­a­tion or phys­ic­al con­tact. The dis­ease is of­ten con­fused with tuber­cu­los­is and some forms of pneu­mo­nia.

Mean­while, the firm Hawaii Bi­otech said it would re­ceive $7.4 mil­lion over half a dec­ade to pre­pare a pos­sible coun­ter­meas­ure for an­thrax tox­in. The fund­ing would come from the Na­tion­al In­sti­tute for Al­lergy and In­fec­tious Dis­eases, ac­cord­ing to a com­pany state­ment.

{{ BIZOBJ (video: 4708) }}

What We're Following See More »
What the Current Crop of Candidates Could Learn from JFK
13 hours ago

Much has been made of David Brooks’s recent New York Times column, in which confesses to missing already the civility and humanity of Barack Obama, compared to who might take his place. In NewYorker.com, Jeffrey Frank reminds us how critical such attributes are to foreign policy. “It’s hard to imagine Kennedy so casually referring to the leader of Russia as a gangster or a thug. For that matter, it’s hard to imagine any president comparing the Russian leader to Hitler [as] Hillary Clinton did at a private fund-raiser. … Kennedy, who always worried that miscalculation could lead to war, paid close attention to the language of diplomacy.”

Maher Weighs in on Bernie, Trump and Palin
14 hours ago

“We haven’t seen a true leftist since FDR, so many millions are coming out of the woodwork to vote for Bernie Sanders; he is the Occupy movement now come to life in the political arena.” So says Bill Maher in his Hollywood Reporter cover story (more a stream-of-consciousness riff than an essay, actually). Conservative states may never vote for a socialist in the general election, but “this stuff has never been on the table, and these voters have never been activated.” Maher saves most of his bile for Donald Trump and Sarah Palin, writing that by nominating Palin as vice president “John McCain is the one who opened the Book of the Dead and let the monsters out.” And Trump is picking up where Palin left off.